|
ZNF561 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.859000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.829600E-01 |
| Normal-vs-Stage2 |
2.319800E-01 |
| Normal-vs-Stage3 |
7.75450000000122E-05 |
| Normal-vs-Stage4 |
1.86720999999501E-05 |
| Stage1-vs-Stage2 |
5.407600E-01 |
| Stage1-vs-Stage3 |
6.42770000000015E-05 |
| Stage1-vs-Stage4 |
2.12679999999077E-05 |
| Stage2-vs-Stage3 |
2.995700E-02 |
| Stage2-vs-Stage4 |
7.535500E-03 |
| Stage3-vs-Stage4 |
5.374000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.501810E-02 |
| Normal-vs-AfricanAmerican |
2.04259999999623E-05 |
| Normal-vs-Asian |
7.935400E-01 |
| Caucasian-vs-AfricanAmerican |
4.282200E-03 |
| Caucasian-vs-Asian |
3.368400E-01 |
| AfricanAmerican-vs-Asian |
3.872100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.338360E-02 |
| Normal-vs-Female |
1.039870E-02 |
| Male-vs-Female |
5.761000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.905800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.249900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.116300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.606000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.423600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.066000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.843600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.200400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.896800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.521400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.843000E-01 |
| Normal-vs-Grade 2 |
7.589200E-01 |
| Normal-vs-Grade 3 |
7.787600E-04 |
| Normal-vs-Grade 4 |
4.82890000208513E-08 |
| Grade 1-vs-Grade 2 |
8.331800E-01 |
| Grade 1-vs-Grade 3 |
2.005000E-01 |
| Grade 1-vs-Grade 4 |
8.198300E-03 |
| Grade 2-vs-Grade 3 |
5.58669999999317E-05 |
| Grade 2-vs-Grade 4 |
6.5948000393945E-09 |
| Grade 3-vs-Grade 4 |
1.982330E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.054800E-01 |
| Normal-vs-ccB subtype |
2.030400E-04 |
| ccA subtype-vs-ccB subtype |
3.06559999607714E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.119600E-02 |
| Normal-vs-N1 |
4.025800E-02 |
| N0-vs-N1 |
1.282400E-01 |
|
|
